BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16507213)

  • 1. Primary non-Hodgkin's lymphoma of the breast: retrospective analysis of prognosis and patterns of failure in two Australian centers.
    Ryan GF; Roos DR; Seymour JF
    Clin Lymphoma Myeloma; 2006 Jan; 6(4):337-41. PubMed ID: 16507213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
    Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D
    Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin lymphoma of the breast.
    Ganjoo K; Advani R; Mariappan MR; McMillan A; Horning S
    Cancer; 2007 Jul; 110(1):25-30. PubMed ID: 17541937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary breast lymphoma--a report of 27 cases with literature review].
    Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
    Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
    Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
    Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consideration of aggressive therapeutic strategies for primary testicular lymphoma.
    Park BB; Kim JG; Sohn SK; Kang HJ; Lee SS; Eom HS; Kwon HC; Oh SY; Kang JH; Oh SJ; Shin HJ; Suh C; Kim JH; Kim HY; Kim K; Ryoo BY; Kim WS
    Am J Hematol; 2007 Sep; 82(9):840-5. PubMed ID: 17563078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution.
    Fukuhara S; Watanabe T; Munakata W; Mori M; Maruyama D; Kim SW; Kobayashi Y; Taniguchi H; Maeshima AM; Tanosaki R; Matsuno Y; Tobinai K
    Eur J Haematol; 2011 Nov; 87(5):434-40. PubMed ID: 21740461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure.
    Ludmir EB; Milgrom SA; Pinnix CC; Gunther JR; Westin J; Oki Y; Fayad LE; Medeiros LJ; Dabaja BS; Nastoupil LJ
    Leuk Lymphoma; 2018 Dec; 59(12):2896-2903. PubMed ID: 29697005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
    Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
    Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High grade primary breast lymphoma: is it a different clinical entity?
    Fruchart C; Denoux Y; Chasle J; Peny AM; Boute V; Ollivier JM; Genot JY; Michels JJ
    Breast Cancer Res Treat; 2005 Oct; 93(3):191-8. PubMed ID: 16172797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
    Ryan G; Martinelli G; Kuper-Hommel M; Tsang R; Pruneri G; Yuen K; Roos D; Lennard A; Devizzi L; Crabb S; Hossfeld D; Pratt G; Dell'Olio M; Choo SP; Bociek RG; Radford J; Lade S; Gianni AM; Zucca E; Cavalli F; Seymour JF;
    Ann Oncol; 2008 Feb; 19(2):233-41. PubMed ID: 17932394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience.
    Wong WW; Schild SE; Halyard MY; Schomberg PJ
    J Surg Oncol; 2002 May; 80(1):19-25; discussion 26. PubMed ID: 11967901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
    Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
    J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma.
    Ibrahim EM; Ezzat AA; Raja MA; Rahal MM; Ajarim DS; Mann B; Baloush A; Stuart RK; Bazarbashi SN
    Ann Oncol; 1999 Dec; 10(12):1441-9. PubMed ID: 10643534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.